These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1921137)

  • 21. Systemic and regional hemodynamic effects of isomazole in awake dogs with congestive heart failure.
    Imai N; Liang CS; Stone CK; Hayes JS; Hood WB
    J Pharmacol Exp Ther; 1987 Apr; 241(1):20-6. PubMed ID: 3572783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of captopril, nitroprusside, dopamine and lanatoside C on a new model of rabbit congestive heart failure.
    Chen X; Fang YX; Xiong WS; Su Z; Hu KL; Wu WJ; Liu ZQ
    Zhongguo Yao Li Xue Bao; 1988 Sep; 9(5):402-8. PubMed ID: 3064549
    [No Abstract]   [Full Text] [Related]  

  • 23. [An experimental study of the cardio- and hemodynamic effects of the carboxyl ionophore monensin].
    Gurbanov KG; Kovalev GV; Paperno AA
    Farmakol Toksikol; 1990; 53(3):17-9. PubMed ID: 2387374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A clinical experience of taurine and trimetazidine use in premenopausal women with chronic heart failure].
    Sedova EM; Magnitskaia OV
    Kardiologiia; 2010; 50(1):62-3. PubMed ID: 20144159
    [No Abstract]   [Full Text] [Related]  

  • 25. [Problems of chronic heart failure].
    Tkaczewski W
    Pol Arch Med Wewn; 1992; 88(2-3):200-6. PubMed ID: 1492027
    [No Abstract]   [Full Text] [Related]  

  • 26. When should we use nitrates in congestive heart failure?
    Vizzardi E; Bonadei I; Rovetta R; D'Aloia A; Quinzani F; Curnis A; Dei Cas L
    Cardiovasc Ther; 2013 Feb; 31(1):27-31. PubMed ID: 22953723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The influence of kordaron on the pharmacodynamic effects of strophanthin in experiments on isolated myocardial preparations and in the modelling of heart failure].
    Lemkina SM
    Eksp Klin Farmakol; 1993; 56(4):30-3. PubMed ID: 8220011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The acute effect of a new positive inotropic agent (AR-L 115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure.
    Hauf GF; Bubenheimer P; Roskamm H
    Arzneimittelforschung; 1981; 31(1a):253-6. PubMed ID: 7195235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S23-30. PubMed ID: 2478788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of ACE inhibitors in heart failure (clinical aspects)].
    Riegger AJ
    Z Kardiol; 1992; 81 Suppl 4():93-6. PubMed ID: 1290309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic effects of calcium-sensitizing agents.
    Vegh A; Papp JG; Udvary E; Kaszala K
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S20-31. PubMed ID: 8907128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of ecdysterone on experimental arrhythmias and changes in the hemodynamics and myocardial contractility induced by coronary artery occlusion].
    Kurmukov AG; Ermishina OA
    Farmakol Toksikol; 1991; 54(1):27-9. PubMed ID: 1860493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A disorder of myocardial contractile function in acute experimental coronary failure: the submolecular mechanisms and the action of cardiac glycosides].
    Karsanov NV; Sukoian GV; Tatulashvili DR; Karsanov VN; Guledani NE
    Eksp Klin Farmakol; 2000; 63(2):24-34. PubMed ID: 10834090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Positive inotropic substances. Possible use in heart failure in the aged].
    Michel D
    Fortschr Med; 1991 Aug; 109(25):496-9. PubMed ID: 1937336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
    Uretsky BF; Valdes AM; Reddy PS
    Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The value of ACE inhibitors in heart failure (mechanism of action)].
    Drexler H
    Z Kardiol; 1992; 81 Suppl 4():85-91. PubMed ID: 1290308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of acetylcarnitine and carnitine on experimental heart failure].
    Han BJ; Liu HP; Tang YZ; Wan BS; Zhou EF
    Yao Xue Xue Bao; 1986 Jul; 21(7):488-91. PubMed ID: 3811936
    [No Abstract]   [Full Text] [Related]  

  • 38. Early changes in contractility indices and fibrosis in two minimally invasive congestive heart failure models.
    de Souza Vilarinho KA; Petrucci O; Baker RS; Vassallo J; Schenka AA; Duffy JY; de Oliveira PP; Vieira RW
    Eur J Cardiothorac Surg; 2010 Feb; 37(2):368-75. PubMed ID: 19945295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [ACE inhibition: mechanisms of cardioprotection in chronic heart failure].
    Dietz R
    Klin Wochenschr; 1991; 69 Suppl 24():24-7; discussion 27-9. PubMed ID: 1865632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The action of a new taurine derivative in different variants of hypoxic states].
    Torkunov PA; Sapronov NS
    Eksp Klin Farmakol; 2000; 63(1):37-40. PubMed ID: 10763108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.